Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Net Margin (2020 - 2025)

Biofrontera (BFRI) has 6 years of Net Margin data on record, last reported at 95.15% in Q3 2025.

  • For Q3 2025, Net Margin fell 3224.0% year-over-year to 95.15%; the TTM value through Sep 2025 reached 47.28%, down 1097.0%, while the annual FY2024 figure was 47.58%, 1150.0% up from the prior year.
  • Net Margin reached 95.15% in Q3 2025 per BFRI's latest filing, down from 58.95% in the prior quarter.
  • Across five years, Net Margin topped out at 57.03% in Q1 2022 and bottomed at 369.45% in Q3 2021.
  • Average Net Margin over 5 years is 73.72%, with a median of 62.53% recorded in 2021.
  • Peak YoY movement for Net Margin: surged 31008bps in 2022, then plummeted -16613bps in 2023.
  • A 5-year view of Net Margin shows it stood at 158.21% in 2021, then soared by 83bps to 27.45% in 2022, then soared by 221bps to 33.28% in 2023, then tumbled by -133bps to 11.12% in 2024, then tumbled by -756bps to 95.15% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 95.15% in Q3 2025, 58.95% in Q2 2025, and 48.94% in Q1 2025.